Evidence map›Paper›PMID 39129149›Full record

Trial reportPediatric blood & cancer2024

Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort.

Rahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, Lenka Ilcisin, Colleen A Kelly, Ariana Valenzuela, Charlotte Bruce, Stephanie Ettinger de Cuba, Peter D Cole, Lisa M Gennarini and 7 more

Registry-linked trialAbstract readClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in Pediatric blood & cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03020030 (Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03020030 phase3active not recruitingnot on this map

Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents

TypeinterventionalSponsorDana-Farber Cancer InstituteRan2017 to 2034Enrolled560ConditionsAcute Lymphoblastic Leukemia, PediatricArmsPegaspargase, Erwinia asparaginase, Cyclophosphamide, CYTARABINE, DASATINIB
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rahela Aziz-BoseDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0003-4753-5144
Colin CernikDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Puja J UmaretiyaDivision of Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-7587-4875
Lenka IlcisinDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0001-8934-5029
Colleen A KellyDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Ariana ValenzuelaDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Charlotte BruceDepartment of Pediatrics, Boston Medical Center, Boston, Massachusetts, USA.
Stephanie Ettinger de CubaDepartment of Health Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts, USA.
Peter D ColeRutgers Cancer Institute, New Brunswick, New Jersey, USA.ORCID 0000-0002-3525-8015
Lisa M GennariniMontefiore Medical Center, Bronx, New York, USA.
Justine M KahnDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0003-3330-6754
Kara M KellyDepartment of Pediatrics, Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Bruno MichonCentre Hospitalier Universitaire de Quebec, Saint-Foy, Quebec, Canada.
Thai-Hoa TranDivision of Pediatric Hematology/Oncology, Charles-Bruneau Cancer Center, CHU Ste-Justine, University of Montreal, Montreal, Quebec, Canada.ORCID 0000-0002-8712-6233
Jennifer J G WelchDivision of Pediatric Hematology/Oncology, Hasbro Children's Hospital/Brown University, Providence, Rhode Island, USA.ORCID 0000-0001-9117-4812
Lewis B SilvermanDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York, USA.
Kira BonaDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0001-5602-7059

Funding

Research Training in Pediatric OncologyT32CA136432 · NCI · DANA-FARBER CANCER INST · PI SCOTT A ARMSTRONG · 2009 to 2026
$7.9M
Leukemia and Lymphoma Society Scholar in Clinical Research Program (JMK)National Cancer Institute at the National Institutes of Health (RAB) T32-CA136432-12NCI NIH HHS T32 CA136432
6 · The paper itself

Abstract

Poverty-exposed children with cancer are more likely to experience adverse outcomes. Supplemental Nutrition Assistance Program (SNAP) benefits improve food insecurity and child health outcomes, and could be used to mitigate disparities. We conducted a secondary analysis of parent-reported data collected in a frontline pediatric leukemia trial (NCT03020030) to assess SNAP eligibility (proxied by other means-tested program participation) and participation. At diagnosis, 105/287 families (37%) were SNAP-eligible, of whom 53 (50%) were SNAP participants. At 6 months, 104/257 families (41%) were SNAP-eligible, and 59 (57%) were SNAP participants. Interventions to increase benefits participation during childhood cancer treatment represent an immediate opportunity to reduce disparities.

Indexed as

Food AssistanceLeukemiaAdolescentChildChild, PreschoolFemaleFollow-Up StudiesFood InsecurityHumansInfantMalePovertyacute lymphoblastic leukemiafood insecurityhealth disparitiessocial determinants of health

Identifiers

PMID39129149
PMCPMC11464176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.